AI assistant
Sending…
SELLAS Life Sciences Group, Inc. — Director's Dealing 2010
Mar 30, 2010
33651_dirs_2010-03-30_1231de7f-cfb9-455b-b836-1ffb9892bcee.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RXI PHARMACEUTICALS CORP (RXII)
CIK: 0001390478
Period of Report: 2010-03-26
Reporting Person: GALLIKER STEPHEN S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-03-26 | Common stock | S | 15000 | $5.54 | Disposed | 10000 | Direct |
More from SELLAS Life Sciences Group, Inc.
Regulatory Filings
2026
Jun 2
Report Publication Announcement
2026
May 12
Interim / Quarterly Report
2026
May 12
Major Shareholding Notification
2026
Mar 27
Capital/Financing Update
2026
Mar 20
Major Shareholding Notification
2026
Jan 30
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9